US Patent:
20030198975, Oct 23, 2003
Inventors:
Yalda Azimzai - Oakland CA, US
Janice Au-Young - Brisbane CA, US
Sajeev Batra - Oakland CA, US
Mariah Baughn - San Leandro CA, US
Shanya Becha - Castro Valley CA, US
Mark Borowsky - Redwood City CA, US
Neil Burford - Durham CT, US
Li Ding - Creve Coeur MO, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ameena Gandhi - San Francisco CA, US
Kimberly Gietzen - San Jose CA, US
Jennifer Griffin - San Jose CA, US
April Hafalia - Santa Clara CA, US
Cynthia Honchell - San Carlos CA, US
Preeti Lal - Santa Clara CA, US
Soo Lee - Daly City CA, US
Dyung Aina Lu - San Jose CA, US
Chandra Arvizu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Roopa Reddy - Sunnyvale CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Y. Tom Tang - San Jose CA, US
Narinder Chawla - Union City CA, US
Yu-Mei Wang - Mountain View CA, US
Bridget Warren - Encinitas CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - San Jose CA, US
Monique Yao - Carmel IN, US
Henry Yue - Sunnyvale CA, US
Yeganeh Zebarjadian - San Francisco CA, US
Assignee:
Incyte Genomics, Inc. - Palo Alto CA
International Classification:
C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06
C07K014/47
A61K048/00
US Classification:
435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 530/350000, 536/023200, 530/388260, 514/044000
Abstract:
The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.